---
schema_version: "secwatch.filing_event.v1"
accession: "0001613103-25-000034"
form_type: "8-K"
ticker: "MDT"
cik: "0001613103"
company_name: "Medtronic plc"
filed_at: "2025-03-17T23:59:59+00:00"
generated_at: "2026-05-24T15:40:31.481975+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Medtronic principal accounting officer Kirk resigns; Blomquist named successor

## Summary
- Jennifer M. Kirk resigns as Global Controller & Principal Accounting Officer effective May 2, 2025 to become CEO of Exubrion Therapeutics.
- Denise L. Blomquist, Assistant Global Controller, appointed as Global Controller & Principal Accounting Officer effective March 17, 2025.
- Blomquist has 21-year Medtronic tenure; compensation aligns with similar officer positions under MIP, LTIP, and Change in Control Policy.
- Kirk's departure not related to any disagreement over operations, policies, or practices; she will stay through May 2 for transition.

## SEC filing metadata
- accession: 0001613103-25-000034
- form_type: 8-K
- ticker: MDT
- cik: 0001613103
- company_name: Medtronic plc
- filed_at: 2025-03-17T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1613103/000161310325000034/0001613103-25-000034-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1613103/000161310325000034/mdt-20250312.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001613103-25-000034
- JSON: https://secwatch.observer/filing/0001613103-25-000034.json
- Plain text: https://secwatch.observer/filing/0001613103-25-000034.txt

## Key facts
- Executive change
  Jennifer M. Kirk resigned as Global Controller and Principal Accounting Officer at Medtronic plc.
  - Action: resigned
  - Role: Global Controller and Principal Accounting Officer
  source text: On March 12, 2025, Jennifer M. Kirk, the Global Controller and Principal Accounting Officer of Medtronic plc (Company), notified the Company of her decision to resign from the Company, effective May 2, 2025, to become the chief executive officer of Exubrion Therapeutics, a privately held company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1613103/000161310325000034/0001613103-25-000034-index.htm
- Executive change
  Denise L. Blomquist was appointed as Global Controller and Principal Accounting Officer at Medtronic plc.
  - Action: appointed
  - Role: Global Controller and Principal Accounting Officer
  source text: The Company has appointed Denise L. Blomquist, currently the Company's Assistant Global Controller, to succeed Ms. Kirk as the Company's Global Controller and Principal Accounting Officer, effective March 17, 2025.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1613103/000161310325000034/0001613103-25-000034-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.